Advertisement

Immunologic Research

, 30:81 | Cite as

The immune system in the elderly

Activation-induced and damage-induced apoptosis
  • Lia Ginaldi
  • Massimo De Martinis
  • Daniela Monti
  • Claudio Franceschi
Article

Abstract

Apoptosis is a complex cell-death process that allows cells to die in a controlled fashion. Our overall health relies to a great extent on the proper balance between the normal removal of damaged or unneeded cells via apoptosis and proliferation of the cells that comprise our body. Increasing evidence suggests that apoptosis is involved in many physiological processes and pathological conditions. It plays an important role during development, in maintaining tissue homeostasis, in responding to cellular damage, and in preventing neoplastic diseases. Apoptosis is a key regulator of clonotypic diversity generation during lymphocyte ontogenesis and is essential for the proper function of the immune system, controlling lymphocyte activation and clonal expansion following antigenic stimulation. There are various types of apoptosis, induced by different kinds of stimuli and in cells and tissues of different natures. On the basis of the nature of the apoptosis-inducing stimuli, two main apoptotic pathways can be identified: an activation-induced apoptosis, initiated by a variety of signals, such as the binding of ligands to their death-promoting receptors on the cell surface, and a damage-induced apoptosis, triggered by a damage to the nucleous or other cellular components. Apoptosis is markedly involved in many changes characteristic of immunosenescence, such as thymic involution, alteration of T-cell repertoire, accumulation of memory/effector cells, and autoimmunity. The intense investigation of the age-related changes occurring in cell-death phenomena and on their precise impact on aging has resulted in controversial data. During senescence, the activation-induced and damage-induced apoptotic pathways could be differentially modulated, with variable impacts on the aging process. Changes in either of these two main apoptotic networks that may occur during aging could lead to disease. A correct modulation of apoptosis may be useful for prolonging the lifespan or at least reducing age-related degenerative and inflammatory pathologies and neoplastic diseases whose incidence increases with age. Careful study of literature together with personal experience in the field of senescence causes us to propose a new reading register that better explains and integrates many of the apparently discordant results.

Key Words

Aging Immune system Apoptosis 

References

  1. 1.
    Franceschi C, Monti D, Sansoni P, Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol Today 1995;16:12–16.PubMedCrossRefGoogle Scholar
  2. 2.
    Fagnoni FF, Vescovini R, Passeri G, et al.: Shortage of circulating naive CD8+T cells provides new insights on immunodeficiency in aging. Blood 2000;95: 2860–2868.PubMedGoogle Scholar
  3. 3.
    Fagnoni FF, Vescovini R, Mazzola M, et al.. Expansion of cytotoxic CD8+CD28-T cells in healthy ageing people, including centenarians. Immunology 1996; 88:501–507.PubMedCrossRefGoogle Scholar
  4. 4.
    Pawelec G, Adibzadeh M, Rehbein A, Hahnel K, Wagner W, Engel A. In vitro senescence models for human T lymphocytes. Vaccine 2000;18:1666–1674.PubMedCrossRefGoogle Scholar
  5. 5.
    Franceschi C, Bonaf M, Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing ical space. Vaccine 2000;18:1717–1720.PubMedCrossRefGoogle Scholar
  6. 6.
    Monti D, Salvioli S, Capri M, et al. Decreased susceptibility to oxidative stress-induced apoptosis of peripheral blood mononuclear cells from healthy elderly and centenarians. Mech Ageing Dev 2000;121:239–250.PubMedCrossRefGoogle Scholar
  7. 7.
    Zhou T, Edwards CK, Mountz JD. Prevention of agerelated T cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 1995;182:129–137PubMedCrossRefGoogle Scholar
  8. 8.
    Spaulding CS, Guo W, Effros DB: Resistance to apoptosis in human CD8+ T cells that reach replicative senescence after multiples rounds of antigenic-specific proliferation. Exp Gerontol 1999;34:633–644.PubMedCrossRefGoogle Scholar
  9. 9.
    Phelouzat MA, Arbogast A, Laforge T, Quadri RA, Proust JJ. Excessive apoptosis of mature T lymphocytes is a characteristic feature of human immune senescence. Mech Ageing Dev 1996;88:25–38.PubMedCrossRefGoogle Scholar
  10. 10.
    Phelouzat MA, Laforge T, Arbogast A, Arbogast A, Quadri RA, Boutet S, Proust JJ. Susceptibility to apoptosis of T lymphocytes from elderly humans is associated with increased in vivo expression of unctional Fas receptors. Mech Ageing Dev 1997;96:35–46.PubMedCrossRefGoogle Scholar
  11. 11.
    Herndon FJ, Hsu H-C, Mountz DJ. Increased apoptosis of CD45RO-T cells with aging. Mech Ageing Dev 1997;94:123–134.PubMedCrossRefGoogle Scholar
  12. 12.
    Potestio M, Caruso C, Gervasi F, et al. Apoptosis and ageing. Mech Ageing Dev 1998;102:221–237.PubMedCrossRefGoogle Scholar
  13. 13.
    Aggarwal S, Gupta S. Increased apoptosis of T cell subset in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 1998;160:1627–1637.PubMedGoogle Scholar
  14. 14.
    Aggarwal S, Gupta S. Increased activity of caspase 3 and caspase 8 in anti-Fas-induced apoptosis in lymphocytes from ageing humans. Clin Exp Immunol 1999;117:285–290.PubMedCrossRefGoogle Scholar
  15. 15.
    Aggarwal S, Gollapudi S, Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Immunol 1999;162:2154–2161.PubMedGoogle Scholar
  16. 16.
    Lechner M, Amort M, Steger MM, Maczek C, Grubeck-Loebstein B. Regulation of CD95 (APO-1) expression and the induction of apoptosis in human T-cells: changes in old age. Int Arch Allergy Immunol 1996;110:238–243.PubMedCrossRefGoogle Scholar
  17. 17.
    Akbar AN, Soares MVD, Plunkett FJ, Salmon M. Differential regulation of CD8+ T cell senescence in mice and men. Mech Ageing Dev 2000;121:69–76.PubMedCrossRefGoogle Scholar
  18. 18.
    Zhang Y, Herman B. Apoptosis and successful aging. Mech Ageing Dev 2002b;123:563–565.PubMedCrossRefGoogle Scholar
  19. 19.
    Campisi J. Cellular senescence and cell death. In: Physiological basis of aging and geriatrics. Third edition. Timiras PS ed. CRC Press, NY 2003, pp. 47–59.Google Scholar
  20. 20.
    Szmit E, Trzonkowski P, Mysliwska J, Foerster J, Mysliwski A. Exvivo apoptotic potential of peripheral blood mononuclear cells of the elderly human subject. Cell Biol Int 2002;26:517–527.PubMedCrossRefGoogle Scholar
  21. 21.
    Skulachev VP. The Programmed death phenomena, aging, and the samurai law of biology. Exp Gerontol 2001;36:995–1024PubMedCrossRefGoogle Scholar
  22. 22.
    Hengartner MO. The biochemistry of apoptosis. Nature 2000;407:770–776.PubMedCrossRefGoogle Scholar
  23. 23.
    Krammer PH. CD95 s deadly mission in the immune system. Nature 2000;407:789–795.PubMedCrossRefGoogle Scholar
  24. 24.
    Zhang Y, Herman B. Ageing and apoptosis. Mech Ageing Dev 2002a;123:245–260.PubMedCrossRefGoogle Scholar
  25. 25.
    Akbar AN, Salmon M. Cellular environments and apoptosis: tissue microenvironments control activated T-cell death. Immunol Today 1997;18:72–76.PubMedCrossRefGoogle Scholar
  26. 26.
    Akhurst R, Derynck R. TGF-signaling in cancer: a double-edged sword. Trends Cell Biol 2001;11:44–51Google Scholar
  27. 27.
    Medh RD, Thompson EB, Hormonal regulation of physiological cell turnover and apoptosis. Cell Tissue Res 2000;301:101–124.PubMedCrossRefGoogle Scholar
  28. 28.
    Shearer GM. Th1/Th2 changes in aging. Mech Ageing Dev 1997;94:1–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Andrew D, Aspinall R, II-7 and not stem cell factor reverses both the increase in apoptosis and the decline in thymopoiesis seen in aged mice. J Immunol 2001; 166;524–1530.Google Scholar
  30. 30.
    Drouet M, Lauthier F, Charnes JP, Sauvage P, Ratinaud MH. Age-associated changes in mitochondrial parmeters on peripheral human lymphocytes. Exp Geronotol 1999;34:843–852.CrossRefGoogle Scholar
  31. 31.
    McLeod JD Apoptotic capability in ageing T cells Mech Ageing Dev 2000;121:151–159.PubMedCrossRefGoogle Scholar
  32. 32.
    Lancelle C, Xu S, Wang E. Identification of high caspase-3 mRNA expression as a unique signature profile for extremely old individuals. Mech. Ageing Dev 2002;123:1133–1144.CrossRefGoogle Scholar
  33. 33.
    Higami Y, Shimokawa I, Tomita M, et al. Aging acceterates but life-long dietary restriction suppresses apoptosis-related Fas expression on hepatocytes. Am J Pathol 1997;151:659–663.PubMedGoogle Scholar
  34. 34.
    Chao DT, Korsmeyer SJ. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998;16:395–419.PubMedCrossRefGoogle Scholar
  35. 35.
    Lee H, Greeley GH Jr, Englander EW. Effects of aging on expression of genes involved in regulation of proliferation and apoptosis in the colonic epithelium. Mech Ageing Dev 2000;155:139–155.CrossRefGoogle Scholar
  36. 36.
    McLeod JD, Walker LSK, Patel YI, Boulougouris G, Sansom DM. Activation of human T cells with superantigen (SEB) and CD28 confers resistance to apoptosis via CD95. J Immunol 1998;160:2072–2079.PubMedGoogle Scholar
  37. 37.
    Bryl E, Vallejo AN, Weyand CM, Goronzy JJ. Downregulation of CD28 expression by TNFα1. J Immunol 2001;167:3231–3238.PubMedGoogle Scholar
  38. 38.
    Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ. Functional properties of CD4+CD28-T cells in the ageing immune system. Mech Ageing Dev 1998:102:131–147.PubMedCrossRefGoogle Scholar
  39. 39.
    Dennet NS, Barcia RN, McLeod JD. Age associated decline in CD25 and CD28 expression correlated with increased susceptibility to CD95 mediated apoptosis in T cells. Exp Gerontol 2002;37:271–283.CrossRefGoogle Scholar
  40. 40.
    Gupta S. Molecular and biochemical pathways of apoptosis in lymphocytes from aged humans. Vaccine 2000;18:1596–1601.PubMedCrossRefGoogle Scholar
  41. 41.
    Gupta S. Molecular steps of cell suicide: an insight into immune senescence. J Clin Immunol 2000;20:229–239.PubMedCrossRefGoogle Scholar
  42. 42.
    Gupta S. Tumor necrosis factor-α-induced apoptosis in T cells from aged humans: a role of TNFR-I and down-stream signaling molecules. Exp Geronntol 2002;37:293–299.CrossRefGoogle Scholar
  43. 43.
    Mishto M, Bonaf M, Salvioli S, Olivieri F, Franceschi C. Age dependent impact of LMP polymorphism on TNFα-induced apoptosis in human peripheral blood mononuclear cells. Exp Gerontol 2002;37:301–308.PubMedCrossRefGoogle Scholar
  44. 44.
    Salvioli S, Capri M, Scarcella E, et al. Age-dependent changes in the susceptibility to apoptosis of peripheral blood CD4+ and CD8+T lymphocytes with virgin or memory phenotype. Mech Ageing Dev 2003 (in press).Google Scholar
  45. 45.
    Kokoszka JE, Coskun P, Esposito LA, Wallace DC. Increased mitochondrial oxidative stress in the Sod2 (+/-) mouse results in the age-related decline of mitochondrial function culminatings in increased apoptosis. Proc Natl Acad Sci USA 2001;98:2278–2283.PubMedCrossRefGoogle Scholar
  46. 46.
    Salvioli S, Bonaf M, Capri M, Monti D, Franceschi C. Mitochondria, aging and longevity—a new perspective. FEBS Letters 2001;492:9–13.PubMedCrossRefGoogle Scholar
  47. 47.
    Remmen HV, Richardson A. Oxidative damage to mitochondria and aging. Exp Gerontol 2001;36:957–968.PubMedCrossRefGoogle Scholar
  48. 48.
    Mattson MP, Duan W, Lee J, Guo Z. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms. Mech Ageing Dev 2001;122:757–778.PubMedCrossRefGoogle Scholar
  49. 49.
    Hasty P, Vijg J. Genomic priorities in aging. Science 2002;296:1250–1251.PubMedCrossRefGoogle Scholar
  50. 50.
    Migliaccio E, Giorgio M, Mele S, et al. The p66shc adaptor protein controls oxidative stress response and life span in mammals. Nature 1999;402:309–313.PubMedCrossRefGoogle Scholar
  51. 51.
    Kops GJL, Dansen TB, Polderman PE, et al. Forkhead transcription factor FOXO3α protects quiescents cells from oxidative stress. Nature 2002;419:316–321.PubMedCrossRefGoogle Scholar
  52. 52.
    Kroemer G, Reed JC. Mitochondrial control of cell death. Nature Med 2000;6:513–519.PubMedCrossRefGoogle Scholar
  53. 53.
    Mather M, Rottenberg H. Aging enhances the activation of the permeability transition pore in mitochondria. Biochem Biophys Res Commun 2000;273:603–608.PubMedCrossRefGoogle Scholar
  54. 54.
    Gershon D. The mitochondrial theory of aging: is the culprit a faulty disposal system rather than indigenous mithocondrial alterations. Exp Gerontol 1999;34:613–619.PubMedCrossRefGoogle Scholar
  55. 55.
    Suh Y, Lee K, Kim W, Han B, Vijg J, Park SC. Aging alters the apoptotic response to genotoxic stress. Nature Med 2002;8:3–4.PubMedCrossRefGoogle Scholar
  56. 56.
    Suh Y. Cell signaling in aging and apoptosis. Mech Ageing Dev 2002;123:881–890.PubMedCrossRefGoogle Scholar
  57. 57.
    Xiao Z, Moragoda L, Jaszewski R, Hatfield JA, Fligiel SEG, Majumdar APN. Aging is associated with increased proliferation and decreased apoptosis in the colonic mucosa. Mech Ageing Dev 2002;122:1849–1864.CrossRefGoogle Scholar
  58. 58.
    Ikeyama S, Kokkonen G, Shack S, Wang XT, Holbrook NJ. Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities. FASEB J 2002;16:114–116.PubMedGoogle Scholar
  59. 59.
    Yoon SO, Yun CH, Chung AS. Dose effect of oxidative stress on signal transduction in aging. Mech Ageing Dev 2002;123:1597–1604.PubMedCrossRefGoogle Scholar
  60. 60.
    Cawthon RM, Smith KR, O’Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 2003;361:393–395.PubMedCrossRefGoogle Scholar
  61. 61.
    Blackburn EH. Telomere states and cell fates. Nature 2000;408:53–56.PubMedCrossRefGoogle Scholar
  62. 62.
    Vaziri H, West MD, Allsopp RC et al. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly (ADP-ribose) polymerase. EMBO J 16:6018–6033.Google Scholar
  63. 63.
    Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000;408:307–310.PubMedCrossRefGoogle Scholar
  64. 64.
    Seluanov A, Falcovitz A, Sigol A, et al. Change in the death pathway in senescent human fibroblasts in response to DNA damage is caused by an inability to stabilize p53. Mol Cell Biol. 2001;21:1552–1564.PubMedCrossRefGoogle Scholar
  65. 65.
    Linskens M, Harley CB, West MD, Campisi J, Hayflick L. Replicative senescence and cell death. Science 1995;267:17.PubMedCrossRefGoogle Scholar
  66. 66.
    Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ. Role of NF-kappa B in the apoptotic-resistant phenotype of keratinocytes. J Biol Chem 1999;274:37957–37964.PubMedCrossRefGoogle Scholar
  67. 67.
    Dimri GP, Lee X, Basile G, et al.: A novel biomarker identifies senescent cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995;92:9363–9367.PubMedCrossRefGoogle Scholar
  68. 68.
    Paradis V, Youssef N, Dargere D, Ba N, Bonvoust F, Bedossa P. Replicative senescence in normal liver, chronic hepatitis C, and hepatocellular carcinomas. Hum Pathol 2001;32:327–332.PubMedCrossRefGoogle Scholar
  69. 69.
    Ding G, Franki N, Kapasi AA, Reddy K, Gibbons N, Singhal PC. Tubular cell senescence and expression of TGF-betal and p21 (WAF1/CIP1) in tubulointerstitial fibrosis of aging rats. Exp Mol Pathol 2001;70:43–53.PubMedCrossRefGoogle Scholar
  70. 70.
    DeJesus V, Rios I, Davis C, et al. Induction of apoptosis in human replicative senescent fibroblasts. Exp Cell Res 2002;274:92–99.PubMedCrossRefGoogle Scholar
  71. 71.
    Wang E, Lee MJ, Pandey S. Control of fibroblast senescence and activation of programmed cell death. J Cell Biochem 1994;54:432–439.PubMedCrossRefGoogle Scholar
  72. 72.
    Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl-2 is involved. Cancer Res 1995;55:2284–2292.PubMedGoogle Scholar
  73. 73.
    Wagner M, Hampel B, Bernhard D, Hala M, Zwerschke W, Jansen-Durr P. Replicative senescence of human endothelial cells in vitro involves G1 arrest, poyploidization and senescence-associated apoptosis. Exp Gerontol 2001;36:1327–1347.PubMedCrossRefGoogle Scholar
  74. 74.
    Pawelec G, Sansom D, Rehbein A, Adibzadeh M, Beckman I. Decreased proliferative capacity and increased susceptibility to activation-induced cell death in late-passage human CD4+TCR2+ cultured T cell clones. Exp Gerontol 1996;31:655–668.PubMedCrossRefGoogle Scholar
  75. 75.
    Rincheval V, Renaud F, Lemaire C, et al. Bcl-2 can promote P53-dependent senescence versus apoptosis without affecting the G1/S transition. Biochem Biophys Res Commun 2002;298:282–288.PubMedCrossRefGoogle Scholar
  76. 76.
    De Boer J, Andressoo JO, de Wit J, et al. Premature aging in mice deficient in DNA repair and transcription. Science 2002;296:1276–1279.PubMedCrossRefGoogle Scholar
  77. 77.
    DePinho RA. The age of cancer. Nature 2000;408:248–254.PubMedCrossRefGoogle Scholar
  78. 78.
    Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci USA 2001;98:12072–12077.PubMedCrossRefGoogle Scholar
  79. 79.
    Verbeke P, Fonager J, Clark BFC, Rattan SIS. Heat shock response and ageing: mechanisms and applications. Cell Biol Internat 2001;25:845–857.CrossRefGoogle Scholar
  80. 80.
    Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol 2003;38:5–11.PubMedCrossRefGoogle Scholar
  81. 81.
    Mattson MP, Duan W, Pedersen WA, Culmsee C. Neurodegenerative disorders and ischemic brain diseases. Apoptosis 2001;6:69–81.PubMedCrossRefGoogle Scholar
  82. 82.
    Schindowski K, Leutner S, Muller WE, Eckert A: Agerelated changes of apoptotic cell death in human lymphocytes. Neurobiol Aging 2000;21:661–670.PubMedCrossRefGoogle Scholar
  83. 83.
    Leri A, Franco S, Zacheo A, et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and herat failure associated with p53 upregulation. EMBO J 2003;22:131–139.PubMedCrossRefGoogle Scholar
  84. 84.
    Hsu H, Shi J, Yang P, et al. Activated CD8+T cells from aged mice exhibit decreased activation-induced cell death. Mech Ageing Dev 2001;122:1663–1684.PubMedCrossRefGoogle Scholar
  85. 85.
    Hyland P, Barnett C, Pawelec G, Barnett Y. Age-related accumulation of oxidative DNA damage and alterations in levels of p16INK4a/CDKN2a, p21WAF1/CIP1/SD11 and p27KIPI in human CD4+T cell clones in vitro. Mech Ageing Dev 2001;122:1151–1167.PubMedCrossRefGoogle Scholar
  86. 86.
    Martin LJ. Neuronal cell death in nervous system development, disease, and injury. Int J Mol Med 2001;7:455–478.PubMedGoogle Scholar
  87. 87.
    Krijnen PAJ, Nijmeijer R, Meijer CJLM, Visser CA, Hack CE, Niessen HWM. Apoptosis in myocardial ischaemia and infarction. J Clin Pathol 2002;55:801–811.PubMedCrossRefGoogle Scholar
  88. 88.
    Ferbeyre G, Lowe SW. The price of tumour suppression? Nature 2002;415:26–27.PubMedCrossRefGoogle Scholar
  89. 89.
    Prives C, Hall PA. The p53 pathway. J Pathol 1999;187:112–126.PubMedCrossRefGoogle Scholar
  90. 90.
    Tyner SD, Venkatachalam S, Choi J, et al. P53 mutant mice that display early ageing-associated phenotypes. Nature 2002;415:45–53.PubMedCrossRefGoogle Scholar
  91. 91.
    Garcia-Cao I, Garcia-Cao M, Martin-Caballero J, et al. Super p53 mice exhibit enhanced DNA damage response, are tumor resistano and age normally. EMBO J 2002;21:6225–6235.PubMedCrossRefGoogle Scholar
  92. 92.
    Seo YR, Kelley M, Smith ML. Selenomethionine regulation of p53 by a ref-1-dependent redox mechanism. Proc Natl Acad Sci USA 2002;99:14548–14553.PubMedCrossRefGoogle Scholar
  93. 93.
    Gudkov AV. Converting p53 from a killer into a healer. Nature Med 2002;8:1196–1198.PubMedCrossRefGoogle Scholar
  94. 94.
    Ginaldi L, Sternberg H. The immune system. In: Physiological basis of aging and geriatrics. Third edition. Timiras PS ed. CRC Press, NY 2003, pp. 265–283.Google Scholar
  95. 95.
    Ginaldi L, De Martinis M, D’Ostilio A, et al. Cell Proliferation and apoptosis in the immune system in the elderly. Immunol Res 2000;21:31–38.PubMedCrossRefGoogle Scholar
  96. 96.
    Hsu H, Zhou T, Shi J, et al. Aged mice exhibit in vivo defective peripheral clonal deletion of D/H-Y reactive CD8+T cells. Mech Ageing Dev 2001;122:305–326.PubMedCrossRefGoogle Scholar
  97. 97.
    Zhang X, Fujil H, Kishimoto H, LeRoy E, Surh CD, Sprent J. Aging leads to disturbed homeostasis of memory phenotype CD8+cells. J Exp Med 2002;195:283–293.PubMedCrossRefGoogle Scholar
  98. 98.
    Grayson JM, Harrington LE, Lanier JG, Wherry EJ, Ahmed R. Differential sensitivity of naive and memory CD8+T cells to apoptosis in vivo. J Immunol 2002;169:3760–3770.PubMedGoogle Scholar
  99. 99.
    Posnett DN, Edinger JW, Manavalan JS, Irwin C, Marodan G. Differentiation of human CD8T cellsimplications for in vivo persistence of CD8+CD28-cytotoxic effector clones. Int Immunol 1999;11:229–241.PubMedCrossRefGoogle Scholar
  100. 100.
    Ohara T, Koyama K, Kusunoki Y, et al. Memory functions and death proneness in three CD4+CD45RO+human T cell subsets. J Immunol 2002;169:39–48.PubMedGoogle Scholar

Copyright information

© Humana Press Inc 2004

Authors and Affiliations

  • Lia Ginaldi
    • 1
  • Massimo De Martinis
    • 1
  • Daniela Monti
    • 2
  • Claudio Franceschi
    • 3
  1. 1.Department of Internal Medicine and Public HealthUniversity of L’AquilaItaly
  2. 2.Department of Experimental Pathology and OncologyUniversity of FlorenceItaly
  3. 3.Department of Experimental PathologyUniversity of BolognaItaly

Personalised recommendations